Stereotactic radiosurgery alone for one to two brain metastases from cancer of unknown primary

Liesa Dziggel, Amira Bajrovic, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aim: The use of stereotactic radiosurgery (SRS) alone has become popular for treating patients with a limited number of brain metastases. In very few patients, the primary tumor leading to cerebral spread is unknown. This study investigated the role of SRS for this rare situation. Patients and Methods: Eight patients with 1-2 brain metastases from cancer of unknown primary (CUP) received SRS alone (median dose 20 Gy). Five clinical factors were evaluated for association with local control of the irradiated lesions, freedom from new cerebral lesions and survival. Results: Six-month and 12-month survival rates were 63% and 63%, respectively. Improved survival was associated with male gender and only one cerebral lesion. Local control rates at 6 and 12 months were 100%. Six-month rate of freedom from new cerebral lesions was 86%. Conclusion: SRS appeared effective and resulted in promising local control and survival rates in patients with 1-2 brain metastases from CUP.

Original languageEnglish (US)
Pages (from-to)565-567
Number of pages3
JournalAnticancer Research
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Radiosurgery
Brain Neoplasms
Neoplasm Metastasis
Survival Rate
Survival
Brain
Neoplasms

Keywords

  • Brain metastases
  • Cancer of unknown primary
  • Freedom from new cerebral lesions
  • Local control
  • Stereotactic radiosurgery
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Stereotactic radiosurgery alone for one to two brain metastases from cancer of unknown primary. / Dziggel, Liesa; Bajrovic, Amira; Schild, Steven E.; Rades, Dirk.

In: Anticancer Research, Vol. 38, No. 1, 01.01.2018, p. 565-567.

Research output: Contribution to journalArticle

Dziggel, Liesa ; Bajrovic, Amira ; Schild, Steven E. ; Rades, Dirk. / Stereotactic radiosurgery alone for one to two brain metastases from cancer of unknown primary. In: Anticancer Research. 2018 ; Vol. 38, No. 1. pp. 565-567.
@article{cec90fae99b246e783ec097caf5eb0f4,
title = "Stereotactic radiosurgery alone for one to two brain metastases from cancer of unknown primary",
abstract = "Background/Aim: The use of stereotactic radiosurgery (SRS) alone has become popular for treating patients with a limited number of brain metastases. In very few patients, the primary tumor leading to cerebral spread is unknown. This study investigated the role of SRS for this rare situation. Patients and Methods: Eight patients with 1-2 brain metastases from cancer of unknown primary (CUP) received SRS alone (median dose 20 Gy). Five clinical factors were evaluated for association with local control of the irradiated lesions, freedom from new cerebral lesions and survival. Results: Six-month and 12-month survival rates were 63{\%} and 63{\%}, respectively. Improved survival was associated with male gender and only one cerebral lesion. Local control rates at 6 and 12 months were 100{\%}. Six-month rate of freedom from new cerebral lesions was 86{\%}. Conclusion: SRS appeared effective and resulted in promising local control and survival rates in patients with 1-2 brain metastases from CUP.",
keywords = "Brain metastases, Cancer of unknown primary, Freedom from new cerebral lesions, Local control, Stereotactic radiosurgery, Survival",
author = "Liesa Dziggel and Amira Bajrovic and Schild, {Steven E.} and Dirk Rades",
year = "2018",
month = "1",
day = "1",
doi = "10.21873/anticanres.12260",
language = "English (US)",
volume = "38",
pages = "565--567",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Stereotactic radiosurgery alone for one to two brain metastases from cancer of unknown primary

AU - Dziggel, Liesa

AU - Bajrovic, Amira

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background/Aim: The use of stereotactic radiosurgery (SRS) alone has become popular for treating patients with a limited number of brain metastases. In very few patients, the primary tumor leading to cerebral spread is unknown. This study investigated the role of SRS for this rare situation. Patients and Methods: Eight patients with 1-2 brain metastases from cancer of unknown primary (CUP) received SRS alone (median dose 20 Gy). Five clinical factors were evaluated for association with local control of the irradiated lesions, freedom from new cerebral lesions and survival. Results: Six-month and 12-month survival rates were 63% and 63%, respectively. Improved survival was associated with male gender and only one cerebral lesion. Local control rates at 6 and 12 months were 100%. Six-month rate of freedom from new cerebral lesions was 86%. Conclusion: SRS appeared effective and resulted in promising local control and survival rates in patients with 1-2 brain metastases from CUP.

AB - Background/Aim: The use of stereotactic radiosurgery (SRS) alone has become popular for treating patients with a limited number of brain metastases. In very few patients, the primary tumor leading to cerebral spread is unknown. This study investigated the role of SRS for this rare situation. Patients and Methods: Eight patients with 1-2 brain metastases from cancer of unknown primary (CUP) received SRS alone (median dose 20 Gy). Five clinical factors were evaluated for association with local control of the irradiated lesions, freedom from new cerebral lesions and survival. Results: Six-month and 12-month survival rates were 63% and 63%, respectively. Improved survival was associated with male gender and only one cerebral lesion. Local control rates at 6 and 12 months were 100%. Six-month rate of freedom from new cerebral lesions was 86%. Conclusion: SRS appeared effective and resulted in promising local control and survival rates in patients with 1-2 brain metastases from CUP.

KW - Brain metastases

KW - Cancer of unknown primary

KW - Freedom from new cerebral lesions

KW - Local control

KW - Stereotactic radiosurgery

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85039803529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039803529&partnerID=8YFLogxK

U2 - 10.21873/anticanres.12260

DO - 10.21873/anticanres.12260

M3 - Article

C2 - 29277825

AN - SCOPUS:85039803529

VL - 38

SP - 565

EP - 567

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1

ER -